Sort By:

ApoE, ApoE Receptors & Neurodegeneration

St. Louis: ApoE Receptors—Hold Sway Over Synaptic Function St. Louis: ApoE—Receptors, Theories and Therapies St. Louis: ApoE—A Clearer View of its Role In AD? The apolipoprotein E gene is the strongest genetic risk factor for late-onset Alzheimer disease. ...

Keystone Symposium: Alzheimer’s Disease Beyond Aβ

Copper Mountain: Can CREB Save Memory? Copper Mountain: Knight Vision—SIRT1 Aids ADAM10, Slays Aβ Copper Mountain Brief: Rat-a-tat—New Model Comes a Knockin’ Copper Mountain: Death and Trophin Receptors—New Insight, New Drugs? Copper Mountain: Fractious ...

American Academy of Neurology: 2010 Annual Meeting

Toronto: 6th Sense—GWAS Picks Up New AD Risk Variant Toronto: Mucke, Miller Share Prestigious Potamkin Prize Toronto: In Small Trial, IVIg Slows Brain Shrinkage American Academy of Neurology: 2010 Annual Meeting ...

International Symposium on ALS/MND, 2012

Chicago—ALS Database Opens for Business Chicago—ALS Protein SOD1 Painted as Disease Template Chicago—ALS Clinical Trials: New Hope After Phase 3 Setbacks Chicago—Devilish Duo: Two Mutations Add Up to Familial ALS Chicago—Dynamic Repeats: C9ORF72 Expands ...

Venusberg Meeting on Neuroinflammation, 2013

Microglia Activation—Venusberg Meeting Questions M1, M2 Designations Inflammatory Crosstalk Between Periphery and Brain Blessing or Curse? Peripheral Cytokines in the Brain Glial Imaging—Amid Slow Progress, EU Project Takes Up Challenge Venusberg Meeting ...

Gladstone Workshop: ApoE4

San Francisco: Tweaking Brain ApoE Reduces Aβ, Symptoms San Francisco: GABA Neurons Blamed for Memory Loss in ApoE Mice Considering the dramatic impact of its E4 allelic variant on Alzheimer’s disease risk, apolipoprotein E arguably has drawn scant ...

Frontotemporal Dementia Treatment: 2011 Study Group Meeting

Las Vegas: Lou Ruvo Center Pioneers New Approach to Clinical Trials Las Vegas: Are Frontotemporal Dementia Models Fit for Pharma? Las Vegas: Can Collaboration Speed Drug Discovery for FTD? The Lou Ruvo Center for Brain Health opened in Las Vegas in 2009 ...

American Academy of Neurology: 2013 Annual Meeting

Quick-and-Early IVIG Therapy: Hints of Promise Anti-Amyloid Results Show Modest Benefits, Mild Side Effects Wrapping Up Enrollment, ADNI 2, PPMI Focus on Earlier Disease Drug Data Dash at AAN Annual Conference The ANN conference in San Diego covered such ...

Current Filters

No filters selected

Filter By

  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From